[1]
Kiran, D.M.D. et al. 2019. Efficacy and Safety of Teneligliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease: ATEND-CKD Study. International Journal of Innovative Research in Medical Science. 4, 01 (Jan. 2019), 16 to 20. DOI:https://doi.org/10.23958/ijirms/vol04-i01/538.